Literature DB >> 1687826

T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice.

A G Harmsen1, M Stankiewicz.   

Abstract

Severe combined immunodeficient (SCID) mice given spleen cells from immunocompetent donors resolve their pre-existing Pneumocystis carinii pneumonia (PCP). However, SCID mice given infusions of thymus cells or spleen cells depleted of cells positive for either immunoglobulin or immune response-associated antigen did not resolve their PCP. Immunofluorescence staining and mitogen responses of spleen cells from the recipient SCID mice confirmed that all groups of mice contained functional T cells but only the mice, reconstituted with nondepleted spleen cells, contained B cells. These results indicate, that T cells alone are not sufficient to resolve PCP in SCID mice and that B cells probably must also be present.

Entities:  

Mesh:

Year:  1991        PMID: 1687826

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  9 in total

1.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Authors:  S A Theus; M J Linke; R P Andrews; P D Walzer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

4.  Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.

Authors:  David J Feola; Beth A Garvy
Journal:  Clin Vaccine Immunol       Date:  2006-02

5.  Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.

Authors:  J M Pascale; M M Shaw; P J Durant; A A Amador; M S Bartlett; J W Smith; R L Gregory; G L McLaughlin
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis.

Authors:  Nelissa Perez-Nazario; Javier Rangel-Moreno; Michael A O'Reilly; Manolis Pasparakis; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

7.  Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.

Authors:  Robert J Blount; Kieran R Daly; Serena Fong; Emily Chang; Katherine Grieco; Meredith Greene; Stephen Stone; John Balmes; Robert F Miller; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 8.  Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections.

Authors:  C M Leopold Wager; F L Wormley
Journal:  Mucosal Immunol       Date:  2014-07-30       Impact factor: 8.701

9.  Ambient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia.

Authors:  Robert J Blount; Kpandja Djawe; Kieran R Daly; Leah G Jarlsberg; Serena Fong; John Balmes; Robert F Miller; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.